Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
3.23
0.15 (4.87%)
At close: Aug 20, 2025, 9:31 AM

Cumberland Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.96M 18.32M 19.76M 27.04M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
13.79M 15.5M 10.05M 12.47M
Receivables
11.7M 9.76M 13.16M 6.88M
Inventory
4M 4.61M 9.4M 8.43M
Other Current Assets
2.79M 3.03M 3.08M 3.34M
Total Current Assets
36.45M 35.71M 45.87M 45.69M
Property-Plant & Equipment
6.45M 7.04M 5.5M 1.47M
Goodwill & Intangibles
18.89M 23.52M 31.5M 24.84M
Total Long-Term Assets
39.13M 46.06M 47.05M 38.77M
Total Assets
75.58M 81.78M 92.93M 84.46M
Account Payables
13.91M 14.04M 10.82M 9.64M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
5.1M n/a n/a n/a
Other Current Liabilities
10.18M 12.4M 16.15M 7.33M
Total Current Liabilities
31.62M 27.98M 28.58M 19.28M
Long-Term Debt
10.18M 12.78M 16.2M 15M
Other Long-Term Liabilities
6.3M 6.45M 7.59M 7.49M
Total Long-Term Liabilities
21.42M 24.53M 28.37M 22.58M
Total Liabilities
53.04M 52.52M 56.95M 41.86M
Total Debt
20.57M 18.43M 20.96M 16.06M
Common Stock
46.82M 47.09M 47.47M 48.45M
Retained Earnings
-23.97M -17.49M -11.21M -5.64M
Comprehensive Income
n/a n/a n/a 0.00
Shareholders Equity
22.85M 29.6M 36.27M 42.81M
Total Investments
-17,964.2B n/a n/a n/a